0001808805-22-000093.txt : 20220816 0001808805-22-000093.hdr.sgml : 20220816 20220816201919 ACCESSION NUMBER: 0001808805-22-000093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220812 FILED AS OF DATE: 20220816 DATE AS OF CHANGE: 20220816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murphy Matthew B. CENTRAL INDEX KEY: 0001865778 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 221171812 MAIL ADDRESS: STREET 1: C/O NAUTILUS BIOTECHNOLOGY, INC. STREET 2: 425 PONTIUS AVE N, STE 202 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 4 1 wf-form4_166069554291105.xml FORM 4 X0306 4 2022-08-12 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001865778 Murphy Matthew B. C/O NAUTILUS BIOTECHNOLOGY, INC. 2701 EASTLAKE AVENUE EAST SEATTLE WA 98102 0 1 0 0 General Counsel Common Stock 2022-08-12 4 P 0 2500 2.85 A 46640 I See Footnote Common Stock 2022-08-15 4 P 0 7500 2.841 A 54140 I See Footnote Common Stock 1250 D Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust. 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan. /s/ Matthew B. Murphy 2022-08-16